HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sabrina Lucchiari Selected Research

Glycogen Storage Disease Type III (Cori's Disease)

10/2018Glucose-free/high-protein diet improves hepatomegaly and exercise intolerance in glycogen storage disease type III mice.
1/2018Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression.
11/2014Glycogen storage disease type III: A novel Agl knockout mouse model.
3/2012Molecular and biochemical characterization of Tunisian patients with glycogen storage disease type III.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sabrina Lucchiari Research Topics

Disease

5Myotonia Congenita (Thomsen Disease)
12/2021 - 07/2012
4Glycogen Storage Disease Type III (Cori's Disease)
10/2018 - 03/2012
2Potassium aggravated myotonia
12/2021 - 05/2016
2Muscle Weakness
01/2018 - 07/2012
2Muscular Diseases (Myopathy)
07/2012 - 09/2004
2type 2B Limb-girdle muscular dystrophy
02/2008 - 09/2004
1Myotonic Dystrophy (Dystrophia Myotonica)
12/2021
1Paralysis (Palsy)
12/2021
1Myotonia
12/2021
1Myotonic Disorders (Paramyotonia Congenita)
12/2021
1Neoplasms (Cancer)
12/2019
1Hypoglycemia (Reactive Hypoglycemia)
10/2018
1Hepatomegaly
10/2018
1Neuromuscular Manifestations
01/2018
1Paresis (Hemiparesis)
06/2017
1Type 1C Limb-Girdle Muscular Dystrophy
02/2008
1Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
02/2008
1Sarcoglycanopathies
02/2008
1type 2E Limb-girdle muscular dystrophy
02/2008
1type 2C Limb-girdle muscular dystrophy
02/2008
1Limb-girdle muscular dystrophy type 2F
02/2008
1Type 2I Limb-Girdle Muscular Dystrophy
02/2008
1Limb-girdle muscular dystrophy type 2A
02/2008
1Miyoshi myopathy
09/2004
1Distal Myopathies (Distal Muscular Dystrophy)
09/2004

Drug/Important Bio-Agent (IBA)

4Chloride Channels (Chloride Channel)IBA
12/2021 - 07/2012
3Glycogen Debranching Enzyme System (Glycogen Debranching Enzyme)IBA
01/2018 - 03/2012
2Mexiletine (Mexitil)FDA LinkGeneric
12/2021 - 06/2017
2GlycogenIBA
10/2018 - 03/2012
2DysferlinIBA
02/2008 - 09/2004
1Protein Kinases (Protein Kinase)IBA
12/2021
1N-desmethylstobadineIBA
12/2021
1Sodium Channels (Sodium Channel)IBA
12/2021
1RNA (Ribonucleic Acid)IBA
12/2019
1Glucose (Dextrose)FDA LinkGeneric
10/2018
1CLC-1 channelIBA
01/2018
1Amino AcidsFDA Link
01/2018
1EnzymesIBA
01/2018
1Peptides (Polypeptides)IBA
01/2018
1ChloridesIBA
06/2017
1DextrinsIBA
03/2012
1amylo-1,6-glucosidaseIBA
03/2012
1Proteins (Proteins, Gene)FDA Link
02/2008
1Sarcoglycans (beta Sarcoglycan)IBA
02/2008

Therapy/Procedure

1High-Protein Diet
10/2018
1Therapeutics
05/2016